<code id='9F87C217F6'></code><style id='9F87C217F6'></style>
    • <acronym id='9F87C217F6'></acronym>
      <center id='9F87C217F6'><center id='9F87C217F6'><tfoot id='9F87C217F6'></tfoot></center><abbr id='9F87C217F6'><dir id='9F87C217F6'><tfoot id='9F87C217F6'></tfoot><noframes id='9F87C217F6'>

    • <optgroup id='9F87C217F6'><strike id='9F87C217F6'><sup id='9F87C217F6'></sup></strike><code id='9F87C217F6'></code></optgroup>
        1. <b id='9F87C217F6'><label id='9F87C217F6'><select id='9F87C217F6'><dt id='9F87C217F6'><span id='9F87C217F6'></span></dt></select></label></b><u id='9F87C217F6'></u>
          <i id='9F87C217F6'><strike id='9F87C217F6'><tt id='9F87C217F6'><pre id='9F87C217F6'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:58
          David L. Ryan/Boston Globe

          A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

          The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

          advertisement

          Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          In search for therapies for solid tumors, companies turn to claudin
          In search for therapies for solid tumors, companies turn to claudin

          MollyFergusonforSTATOnTargetisarecurringfeaturefromSTATthatdivesdeepintothemostpromisingdrugtargetsi

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Biotech companies concerned about China biosecurity crackdown

          AdobeWASHINGTON—ThefederalgovernmentincreasinglyisscrutinizingChinesebusinessesandtheirinteractionsw